Investors
![](https://chromatan.com/wp-content/uploads/2023/06/merck-1024x299.png)
![](https://chromatan.com/wp-content/uploads/2023/06/takeda-1024x344.png)
![](https://chromatan.com/wp-content/uploads/2023/06/20201106_cpub_spark_logo-1024x368.png)
![](https://chromatan.com/wp-content/uploads/2023/06/2560px-MIT_logosvg-1024x530.png)
![](https://chromatan.com/wp-content/uploads/2023/06/pennstate.png)
![](https://chromatan.com/wp-content/uploads/2023/06/NIIMBL-1024x536.jpg)
![](https://chromatan.com/wp-content/uploads/2023/06/Purolite.png)
![](https://chromatan.com/wp-content/uploads/2023/06/proconex.png)
Industry Traction
2022
- Raised $2.1m Bridge
- Solid POC for 2 paid client development programs
2023
- Raised $2.4m Bridge
- Appointed CEO (Q2)
- Launch go-to-market strategy for PD units (Q3)
2024
- Deliver first PD units (Q1)
- Deliver cGMP unit
- Deliver first large-scale CCTC unit (Q4)
2025
- Scale revenue
- Pursue new applications
Funding
$
0
m Raised
$
0
m Awarded from the FDA, NIH, & NIIMBL
Company Presentation
Note: Please download and view in the latest version of the Adobe Acrobat desktop app for a better viewing experience. Make sure “enable playing of Multimedia and 3D content” is checked off under “Menu > Preferences > Multimedia and 3D” to enable video playback. Thank you!
Are you interested in investing with ChromaTan?
Contact us to learn more about how our innovative biomanufacturing solutions fast-track product development.